12thKumamoto AIDS Seminar Global COE Joint International Symposium

Symposium@@@@@
@@@
¡@October 19th, Wednesday
¡@October 20th, Thursday
¡@October 21th, Friday



¡3rd@October 21th, Friday @( Aso Resort GRANDVRIO Hotel 8:30-15:20 )
* In the morning sections, venue is divided into group A and B. 
Young Investigator Symposium : Group A@ 8:30-11:40
YIS-A Session ‡T
8:30-9:50 k80l
Chair: Masateru Hiyoshi & Kazuaki Monde [Kumamoto Univ.]

20
Peter Gee
[Kyoto University, Japan]
Biochemical characterization of the HIV-1 restriction factor SAMHD1

21
Katsuhiro Io
[Kyoto University, Japan]
Phosphorylation of p53 is enhanced by HIV-1 Vif and required for Vif-induced G2 cell cycle arrest and apoptosis

22
Nobuyo Higashi-Kuwata
[Kumamoto University, Japan]
Alteration of the dynamics of HIVmc dissemination in huPBMC NOJ mice under Raltegravir administration

23
Shigeyoshi Harada
[Kumamoto University, Japan]
Impact of raltegravir pressure on the selection of HIV-1 envelope sequences in vitro
YIS-A Session ‡U@
10:20-11:40 k80l
Chair: Masayuki Amano & Shigeyoshi Harada [Kumamoto Univ.]
24
Kazuhiko Maeda
[Kumamoto University, Japan]
GANP promotes APOBEC3G encapsidation in virions to reduce viral infectivity

25
Kazuaki Monde
[Kumamoto University, Japan]
Coassembly of HERV-K Gag with HIV-1 Gag

26
Koji Watanabe
[NCGM / Kumamoto University, Japan]
Clinical and epidemiological features of amebiasis in HIV-1-infected Japanese men

27
Atsuko Hachiya
[NCGM, Japan]
HIV-1 Reverse Transcriptase (RT) Polymorphism 172K, Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors
 
Young Investigator Symposium : Group B 8:30-11:40
YIS-B Session ‡T
8:30-9:50 k80l
Chair: Philip Mwimanzi [Kumamoto Univ.] & Zabrina L. Brumme [Simon Fraser Univ., Canada]
28
Ken Kono
[Osaka University, Japan]
Functional and geographical diversity of antiretroviral host factor TRIMCyp in Cynomolgus macaque (Macaca fascicularis)

29
Chihiro Motozono
[Cardiff University, UK]
The cross-reactivity footprints of HIV-specific CTLs

30
Yusuke Takahara
[NIID, Japan]
Impact of therapeutic vaccination during HAART on CTL immunodominance in SIV infection

31
Takayuki Chikata
[Kumamoto University, Japan]
HLA-Associated Viral Polymorphism in Chronically HIV-1-Infected Japanese Cohort
YIS-B Session ‡U@
10:15-11:40 k85l
Chair: Keiko Sakai & Madoka Koyanagi [Kumamoto Univ.]
32
Takeo Kuwata
[Kumamoto University, Japan]
Biased induction of neutralizing antibodies with particular specificity and gene usage in SIVsmH635FC-infected macaques

33
Philip Mwimanzi
[Kumamoto University, Japan]
Population analysis of viral replication capacity by nef alleles of HIV elite controllers

34
Thumbi Ndung’u
[University of KwaZulu-Natal., South-Africa]
‚hmpact of immune-driven sequence variation in hiv-1 gag-protease on viral replication capacity and disease progression

35
Kazuo Suzuki
[St Vincent's Centre for Applied Medical Research, Australia]
Sequence specific induction of HIV-1 transcriptional gene silencing targeting NF-κB sequences by siRNA without any off-target effects of other NF-B driven genes
 
* In the afternoon sections, groups joint venue
Session XII
13:20-13:40 k20l
Chair: Takeo Kuwata & Masao Hashimoto [Kumamoto Univ.]
36
Best Poster Award winner presentation
Hiromi Ogata-Aoki [Kumamoto University, Japan]
Session XIII
13:40-14:30 k50l
Chair: Yasuo Ariumi [Kumamoto Univ.]
37 Hiroyuki Gatanaga
[NCGM / Kumamoto University, Japan ]
Naturally arising V3 mutations associated with HIV-1 tropism change
38
Zabrina L. Brumme
[Simon Fraser University, Canada]
Adaptation of HIV-1 to immune selection pressure: trends from the North American epidemic

Session XIV
14:30-15:15 k45l
Chair: Seiji Okada [Kumamoto Univ.]
39
Shuzo Matsushita
[Kumamoto University, Japan]
Cross-subtype reactivity and neutralization activity of a panel of human monoclonal antibodies obtained from a single donor

40
Kazuhisa Yoshimura
[Kumamoto University, Japan]
Two-step escape pathway of the HIV-1 primary isolates induced by the in vitro selection of maraviroc

©October 19th, Wednesday
©October 20th, Thursday
   
Home(Japanese)    
Home(English)